Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS-2 promoter activity

Journal of Neurochemistry

Volumn 70, Issue 4, 1998, Pages 1484-1496

  Feinstein, Douglas L ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Astrocyte; Cyclic AMP; Cytokines; Endotoxin; Nitric oxide; Nuclear factor B

Indexed keywords

CYCLIC AMP; CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; GENE EXPRESSION; INFLAMMATION; NERVE CELL CULTURE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; TRANSCRIPTION REGULATION;

EID: 0031883044     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70041484.x     Document Type: Article

References (71)

1. Andersen H. U., Mauricio D., Karlsen A. E., Mandrup-Poulsen T., Nielsen J. H., and Nerup J. (1996) Interleukin-1 beta-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine. Eur. J. Endocrinol. 134, 251-259.
2. Baeuerle P. A. and Henkel T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
3. Bo L., Dawson T. M., Wesselingh S., Mork S., Choi S., Kong P. A., Hanley D., and Trapp B. D. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778-786.
4. Bulut V., Severn A., and Liew F. Y. (1993) Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem. Biophys. Res. Commun. 195, 1134-1138.
5. Cardinaux J. R. and Magistretti P. J. (1996) Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism. J. Neurosci. 16, 919-929.
6. Chandler L. J., Kopnisky K., Richards E., Crews F. T., and Sumners C. (1995) Angiotensin II decreases inducible nitric oxide synthase expression in rat astroglial cultures. Am. J. Physiol. 268, C700-C707.
7. Chelmicka-Shorr E., Kwasniewski M. N., Thomas B. E., and Arnason B. G. W. (1989) The β-adrenergic agonist isoproterenol suppresses EAE in Lewis rats. J. Neuroimmunol. 25, 203-207.
8. Chen D. and Rothenberg E. V. (1994) Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179, 931-942.
9. Cross A. H., Misko T. P., Lin R. F., Hickey W. F., Trotter J. L., and Tilton R. G. (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684-2690.
10. Dinerman J. L., Steiner J. P., Dawson T. M., Dawson V., and Snyder S. H. (1994) Cyclic nuclcotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 33, 1245-1251.
11. Eberhardt W., Kunz D., and Pfeilschifter J. (1994) Pyrrolidine dithiocarbamate differentially affects interleukin 1 beta-and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 200, 163-170.
12. Eberhardt W., Kunz D., Hummel R., and Pfeilschifter J. (1996) Molecular cloning of the rat inducible nitric oxide synthase aene promoter. Biochem. Biophys. Res. Commun. 223, 752-756.
13. Endoh M., Maiese K., Pulsinelli W. A., and Wagner J. A. (1993) Reactive astrocytes express NADPH diaphorase in vivo after transient ischemia. Neurosci. Lett. 154, 125-128.
14. Feinstein D. L. and Rozelman E. (1997) Norepinephrine suppresses L-arginine uptake in rat glial cells. Neurosci. Lett. 223, 37-40.
15. Feinstein D. L., Galea E., and Reis D. J. (1993) Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem. 60, 1945-1948.
16. Feinstein D. L., Galea E., Roberts S., Berquist H., Wang H., and Reis D. J. (1994) Induction of nitric oxide synthase in rat C6 glioma cells. J. Neurochem. 62, 315-321.
17. Feinstein D. L., Galea E., Aquino D. A., Li G. C., Xu H., and Reis D. J. (1996) Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NF-kappa B activation. J. Biol. Chem. 271, 17724-17732.
18. Feinstein D. L., Galea E., and Reis D. J. (1997) Suppression of glial nitric oxide synthase induction by heat shock: effects on proteolytic degradation of IκB-α. Nitric Oxide Chem. Biol. 2, 167-176.
19. Frohman E. M., Vayuvegula B., van den Noort S., and Gupta S. (1988) Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes. J. Neuroimmunol. 17, 89-101.
20. Galea E., Feinstein D. L., and Reis D. J. (1992) Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA 89, 10945-10949.
21. Galea E., Reis D. J., and Feinstein D. L. (1994) Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37, 406-414.
22. Gao J. J., Morrison D. C., Parmely T. J., Russell S. W., and Murphy W. J. (1997) An interferon-gamma activated site is necessary for full expression of the mouse iNOS gene in response to interferon gamma and lipopolysaccharide. J. Biol. Chem. 272, 1226-1230.
23. Genain C. P., Roberts T., Davis R. L., Nguyen M. H., Uccelli A., Faulds D., Li Y., Hedgpeth J., and Hauser S. L. (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 92, 3601-3605.
24. Ghersa P., Hooft van Huijsduijnen R., Whelan J., Cambet Y., Pescini R., and DeLamarter J. F. (1994) Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J. Biol. Chem. 269, 29129-29137.
25. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., and Tannenbaum S. R. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138.
26. Grenfell S. J., Latchman D. S., and Thomas N. S. (1996) Oct-1 [corrected] and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases. Biochem. J. 315, 889-893.
27. Griscavage J. M., Wilk S., and Ignarro L. J. (1996) Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA 93, 3308-3312.
28. Harbrecht B. G., McClure E. A., Simmons R. L., and Billiar T. R. (1995) Prostanoids inhibit Kupffer cell nitric oxide synthesis. J. Surg. Res. 58, 625-629.
29. Harbrecht B. G., Wirant E. M., Kim Y. M., and Billiar T. R. (1996) Glucagon inhibits hepatocyte nitric oxide synthesis. Arch. Surg. 131, 1266-1272.
30. Hauser G. J., Dayao E. K., Wasserloos K., Pitt B. R., and Wong H. R. (1996) HSP induction inhibits iNOS mRNA expression and attenuates hypotension in endotoxin challenged rats. Am. J. Physiol. 40, H2529-H2535.
31. Hewett S. J., Corbett J. A., McDaniel M. L., and Choi D. W. (1993) Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164, 229-232.
32. Hu X. X., Goldmuntz E. A., and Brosnan C. F. (1991) The effect of norepinephrine on endotoxin-mediated macrophage activation. J. Neuroimmunol. 31, 35-42.
33. Imai T., Hirata Y., Kanno K., and Marumo F. (1994) Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93, 543-549.
34. Koide M., Kawahara Y., Nakayama I., Tsuda T., and Yokoyama M. (1993) Cyclic AMP-elevating agents induced an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. J. Biol. Chem. 268, 24959-24966.
35. Kolyada A. Y., Savikovsky N., and Madias N. E. (1996) Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem. Biophys. Res. Commun. 220, 600-605.
36. Koprowski H., Zheng Y. M., Heber-Katz E., Fraser N., Rorke L., Fu Z. F., Hanlon C., and Dietzshold B. (1993) In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90, 3024-3027.
37. Kunz D., Muhl H., Walker G., and Pfeilschifter J. (1994) Two distinc signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc. Natl. Acad. Sci. USA 91, 5387-5391.
38. Lee S. C., Dickson D. W., Liu W., and Brosnan C. F. (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J. Neuroimmunol. 46, 1924.
39. Lin H. S. and Murphy S. (1997) Regulation of astrocyte nitric oxide synthase type II expression by ATP and glumate involves loss of transcription factor binding to DNA. J. Neurochem. 69, 612-616.
40. Marotta P., Sautebin L., and Di Rosa M. (1992) Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107, 640-641.
41. Masquilier D. and Sassone-Corsi P. (1992) Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J. Biol. Chem. 267, 22460-22466.
42. Messmer U. K. and Brune B. (1994) Modulation of inducible nitric oxide synthase in RINm5F cells. Cell. Signal. 6, 17-24.
43. Minghetti L., Nicolini A., Polazzi E., Creminon C., Maclout J., and Levi G. (1997) Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E(2) and by cyclooxygenase inhibitors. Glia 19, 152-160.
44. Mulsch A., Schray-Utz B., Mordvintcev P. I., Hauschildt S., and Busse R. (1993) Diethyldithiocarbamate inhibits induction of m acrophage NO synthase. FEBS Lett. 321, 215-218.
45. Muroi M. and Suzuki T. (1993) Role of protein kinase A in LPS-induced activation of NF-kappa B proteins of a mouse macrophage-like cell line J774. Cell. Signal. 5, 289-298.
46. Murphy S., Simmons M. L., Agullo L., Garcia A., Feinstein D. L., Galea E., Reis D. J., Minc-Golomb D., and Schwartz J. P. (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16, 323-328.
47. Murphy S., Lin H. S., and Park S. K. (1995) Cyotkine-induced expression of type II nitric oxide synthase in astrocytes is down-regulated by ATP and glutamate. Glia 15, 77-82.
48. Nisoli E., Tonello C., Briscini L., and Carruba M. O. (1997) Inducible nitric oxide synthase in rat brown adipocytes - implications for blood flow to brown adipose tissue. Endocrinology 138, 676-682.
49. Oddis C. V., Simmons R. L., Hattler B. G., and Finkel M. S. (1995) cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am. J. Physiol. 269, H2044-H2050.
50. Okuda S., Kanda F., Kawahara Y., and Chihara K. (1997) Regulation of inducible nitric oxide synthase expression in L6 rat skeletal muscle cells. Am. J. Physiol. 41, C35-C40.
51. Ollivier V., Parry G. C. N., Cobb R. R., de Prost D., and Mackman N. (1996) Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271, 20828-20835.
52. Pahan K., Namboodiri A. M., Sheikh F. G., Smith B. T., and Singh I. (1997) Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 272, 7786-7791.
53. Park S. K., Grzybicki D., Lin H. L., and Murphy S. (1994) Modulation of inducible nitric oxide synthase expression in astroglial cells. Neuropharmacology 33, 1419-1423.
54. Perrella M. A., Patterson C., Tan L., Yet S. F., Hsieh C. M., Yoshizumi M., and Lee M. E. (1996) Suppression of interleukin-1 beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta 1 in vascular smooth muscle cells - evidence for mechanisms other than NF-kappa B. J. Biol. Chem. 271, 13776-13780.
55. Raddassi K., Petit J. F., and Lemaire G. (1993) LPS-induced activation of primed murine peritoneal macrophages is modulated by prostaglandins and cyclic nucleotides. Cell. Immunol. 149, 50-64.
56. Satriano J. and Schlondorff D. (1994) Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′ monophosphate. Evidence for involvement of reactive oxygen species. J. Clin. Invest. 94, 1629-1636.
57. Sengupta T. K., Schmitt E. M., and Ivashkiv L. B. (1996) Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc. Natl. Acad. Sci. USA 93, 9499-9504.
58. Serkkola E. and Hurme M. (1993) Activation of NF-kappa B by cAMP in human myeloid cells. FEBS Lett. 334, 327-330.
59. Simmons M. L. and Murphy S. (1992) Induction of nitric oxide synthase in glial cells. J. Neurochem. 59, 897-905.
60. Simmons M. L. and Murphy S. (1993) Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur. J. Neurosci. 5, 825-831.
61. Sommer N., Loschmann P. A., Northoff G. H., Weller M., Steinbrecher A., Steinbach J. P., Lichtenfels R., Meyermann R., Riethmuller A., and Fontana A. (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis [see comments]. Nat. Med. 1, 244-248.
62. Sowa G. and Przewlocki R. (1994) cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur. J. Pharmacol. 266, 125-129.
63. Spink J., Cohen J., and Evans T. J. (1995) The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B. J. Biol. Chem. 270, 29541-29547.
64. Szabo C., Hasko G., Zingarelli B., Nemeth Z. H., Salzman A. L., Kvetan V., Pastores S. M., and Vizi E. S. (1997) Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 a and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 90, 95-100.
65. Tsuruta L., Lee H. J., Masuda E. S., Koyano-Nakagawa N., Arai N., Arai K., and Yokota T. (1995) Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP. J. Immunol 154, 5255-5264.
66. Wallace M. N. and Bisland S. K. (1994) NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase. Neuroscience 59, 905-919.
67. Watanabe S., Yssel H., Harada Y., and Arai K. (1994) Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine production. Int. Immunol. 6, 523-532.
68. Willis S. A. and Nisen P. D. (1995) Inhibition of lipopolysaccharide-induced IL-1 beta transcription by cyclic adenosine monophosphate in human astrocytic cells. J. Immunol. 154, 1399-1406.
69. Xie Q. and Nathan C. (1994) The high-output nitric oxide pathway: role and regulation. J. Leukocyte Biol. 56, 576-582.
70. Xie Q. W., Kashiwabara Y., and Nathan C. (1994) Role of transcription factor nf-kappa b/rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708.
71. Zheng Y. M., Schafero M. K., Weihe E., Sheng H., Corisdeo S., Fu Z. F., Koprowski H., and Dietzschold B. (1993) Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J. Virol. 67, 5786-5791.